Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
1.
Nat Commun ; 12(1): 3316, 2021 06 03.
Article in English | MEDLINE | ID: mdl-34083524

ABSTRACT

The methylglyoxal-derived hydroimidazolone isomer, MGH-1, is an abundant advanced glycation end-product (AGE) associated with disease and age-related disorders. As AGE formation occurs spontaneously and without an enzyme, it remains unknown why certain sites on distinct proteins become modified with specific AGEs. Here, we use a combinatorial peptide library to determine the chemical features that favor MGH-1. When properly positioned, tyrosine is found to play an active mechanistic role that facilitates MGH-1 formation. This work offers mechanistic insight connecting multiple AGEs, including MGH-1 and carboxyethylarginine (CEA), and reconciles the role of negative charge in influencing glycation outcomes. Further, this study provides clear evidence that glycation outcomes can be influenced through long- or medium-range cooperative interactions. This work demonstrates that these chemical features also predictably template selective glycation on full-length protein targets expressed in mammalian cells. This information is vital for developing methods that control glycation in living cells and will enable the study of glycation as a functional post-translational modification.


Subject(s)
Glycation End Products, Advanced/metabolism , Proteins/metabolism , Amino Acid Sequence , Arginine/analogs & derivatives , Arginine/chemistry , Arginine/metabolism , Glycation End Products, Advanced/chemistry , Glycosylation , HEK293 Cells , Humans , Imidazoles/chemistry , Imidazoles/metabolism , Isomerism , Peptide Library , Protein Processing, Post-Translational , Proteins/chemistry , Proteins/genetics , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/chemistry , Pyruvaldehyde/metabolism
2.
Molecules ; 25(24)2020 Dec 09.
Article in English | MEDLINE | ID: mdl-33317096

ABSTRACT

Galega officinalis L. has been known for centuries as an herbal medicine used to alleviate the symptoms of diabetes, but its comprehensive chemical composition and pharmacological activity are still insufficiently known. The current study involved the qualitative and quantitative phytochemical analysis and in vitro evaluation of the antioxidative and methylglyoxal (MGO) trapping properties of galega herb. Ultra high-performance liquid chromatography coupled with both the electrospray ionization mass spectrometer and diode-array detector (UHPLC-ESI-MS and UHPLC-DAD) were used to investigate the composition and evaluate the anti-MGO capability of extracts and their components. Hot water and aqueous methanol extracts, as well as individual compounds representing phytochemical groups, were also assessed for antioxidant activity using DPPH (2,2-diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl) and ABTS (2,2'-azino-bis(3-ethylbenz-thiazoline-6-sulfonic acid) assays. Quercetin and metformin were used as a positive control. We confirmed the presence of tricyclic quinazoline alkaloids, guanidines, flavonoids, and hydroxycinnamic acids (HCAs) in galega extracts. The polyphenolic fraction was dominated by mono-, di-, and triglycosylated flavonols, as well as monocaffeoylhexaric acids. The in vitro tests indicated which G. officinalis components exhibit beneficial antioxidative and MGO trapping effects. For galega extracts, flavonols, and HCAs, a potent antiradical activity was observed. The ability to trap MGO was noted for guanidines and flavonoids, whereas HCA esters and quinazoline alkaloids were ineffective. The formation of mono-MGO adducts of galegine, hydroxygalegine, and rutin in the examined water infusion was observed.


Subject(s)
Antioxidants/chemistry , Galega/chemistry , Phytochemicals/chemistry , Alkaloids/chemistry , Antioxidants/pharmacology , Chromatography, High Pressure Liquid , Flavonoids/chemistry , Guanidines/chemistry , Hydroxybenzoates/chemistry , In Vitro Techniques , Medicine, Traditional , Molecular Structure , Phytochemicals/pharmacology , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Preparations/chemistry , Plant Preparations/pharmacology , Plants, Medicinal/chemistry , Polyphenols/chemistry , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/chemistry , Quinazolines/chemistry , Spectrometry, Mass, Electrospray Ionization
3.
Inorg Chem ; 59(4): 2594-2603, 2020 Feb 17.
Article in English | MEDLINE | ID: mdl-32011880

ABSTRACT

Glyoxalase I (GlxI) is a member of the glyoxalase system, which is important in cell detoxification and converts hemithioacetals of methylglyoxal (a cytotoxic byproduct of sugar metabolism that may react with DNA or proteins and introduce nucleic acid strand breaks, elevated mutation frequencies, and structural or functional changes of the proteins) and glutathione into d-lactate. GlxI accepts both the S and R enantiomers of hemithioacetal, but converts them to only the S-d enantiomer of lactoylglutathione. Interestingly, the enzyme shows this unusual specificity with a rather symmetric active site (a Zn ion coordinated to two glutamate residues; Glu-99 and Glu-172), making the investigation of its reaction mechanism challenging. Herein, we have performed a series of combined quantum mechanics and molecular mechanics calculations to study the reaction mechanism of GlxI. The substrate can bind to the enzyme in two different modes, depending on the direction of its alcoholic proton (H2; toward Glu-99 or Glu-172). Our results show that the S substrate can react only if H2 is directed toward Glu-99 and the R substrate only if H2 is directed toward Glu-172. In both cases, the reactions lead to the experimentally observed S-d enantiomer of the product. In addition, the results do not show any low-energy paths to the wrong enantiomer of the product from neither the S nor the R substrate. Previous studies have presented several opposing mechanisms for the conversion of R and S enantiomers of the substrate to the correct enantiomer of the product. Our results confirm one of them for the S substrate, but propose a new one for the R substrate.


Subject(s)
Glutathione/analogs & derivatives , Lactoylglutathione Lyase/chemistry , Pyruvaldehyde/analogs & derivatives , Density Functional Theory , Humans , Models, Chemical , Protons , Stereoisomerism
4.
Cell Chem Biol ; 27(2): 206-213.e6, 2020 02 20.
Article in English | MEDLINE | ID: mdl-31767537

ABSTRACT

Post-translational modifications (PTMs) regulate enzyme structure and function to expand the functional proteome. Many of these PTMs are derived from cellular metabolites and serve as feedback and feedforward mechanisms of regulation. We have identified a PTM that is derived from the glycolytic by-product, methylglyoxal. This reactive metabolite is rapidly conjugated to glutathione via glyoxalase 1, generating lactoylglutathione (LGSH). LGSH is hydrolyzed by glyoxalase 2 (GLO2), cycling glutathione and generating D-lactate. We have identified the non-enzymatic acyl transfer of the lactate moiety from LGSH to protein Lys residues, generating a "LactoylLys" modification on proteins. GLO2 knockout cells have elevated LGSH and a consequent marked increase in LactoylLys. Using an alkyne-tagged methylglyoxal analog, we show that these modifications are enriched on glycolytic enzymes and regulate glycolysis. Collectively, these data suggest a previously unexplored feedback mechanism that may serve to regulate glycolytic flux under hyperglycemic or Warburg-like conditions.


Subject(s)
Glutathione/analogs & derivatives , Lysine/metabolism , Thiolester Hydrolases/metabolism , Alkynes/chemistry , Glutathione/chemistry , Glutathione/metabolism , Glycolysis/drug effects , Glycosylation , HEK293 Cells , Humans , Lactoylglutathione Lyase/deficiency , Lactoylglutathione Lyase/genetics , Lactoylglutathione Lyase/metabolism , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/chemistry , Pyruvaldehyde/pharmacology , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Thiolester Hydrolases/deficiency , Thiolester Hydrolases/genetics
5.
Int J Mol Sci ; 20(15)2019 Jul 26.
Article in English | MEDLINE | ID: mdl-31357424

ABSTRACT

Seeds represent the major source of food protein, impacting on both human nutrition and animal feeding. Therefore, seed quality needs to be appropriately addressed in the context of viability and food safety. Indeed, long-term and inappropriate storage of seeds might result in enhancement of protein glycation, which might affect their quality and longevity. Glycation of seed proteins can be probed by exhaustive acid hydrolysis and quantification of the glycation adduct Nɛ-(carboxymethyl)lysine (CML) by liquid chromatography-mass spectrometry (LC-MS). This approach, however, does not allow analysis of thermally and chemically labile glycation adducts, like glyoxal-, methylglyoxal- and 3-deoxyglucosone-derived hydroimidazolones. Although enzymatic hydrolysis might be a good solution in this context, it requires aqueous conditions, which cannot ensure reconstitution of seed protein isolates. Because of this, the complete profiles of seed advanced glycation end products (AGEs) are not characterized so far. Therefore, here we propose the approach, giving access to quantitative solubilization of seed proteins in presence of sodium dodecyl sulfate (SDS) and their quantitative enzymatic hydrolysis prior to removal of SDS by reversed phase solid phase extraction (RP-SPE). Using methylglyoxal-derived hydroimidazolone 1 (MG-H1) as a case example, we demonstrate the applicability of this method for reliable and sensitive LC-MS-based quantification of chemically labile AGEs and its compatibility with bioassays.


Subject(s)
Imidazoles/chemistry , Plant Proteins/chemistry , Plant Proteins/metabolism , Pyruvaldehyde/chemistry , Seeds/chemistry , Chromatography, Liquid , Glycation End Products, Advanced/chemistry , Glycation End Products, Advanced/metabolism , Glycosylation , Hydrolysis , Mass Spectrometry , Plant Proteins/isolation & purification , Pyruvaldehyde/analogs & derivatives , Reproducibility of Results , Seeds/metabolism , Solid Phase Extraction , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
6.
ACS Chem Biol ; 13(12): 3294-3305, 2018 12 21.
Article in English | MEDLINE | ID: mdl-30508371

ABSTRACT

Methylglyoxal (MG) is quantitatively the most important precursor to advanced glycation end-products (AGEs), and evidence is accumulating that it is also a causally linked to diabetes and aging related diseases. Living systems primarily reside on the glyoxalase system to detoxify MG into benign d-lactate. The flux to either glycation or detoxification, accordingly, is a key parameter for how well a system handles the ubiquitous glyoxal burden. Furthermore, insight into proteins and in particular their individual modification sites are central to understanding the involvement of MG and AGE in diabetes and aging related diseases. Here, we present a simple method to simultaneously monitor the flux of MG both to d-lactate and to protein AGE formation in a biological sample by employing an alkyne-labeled methylglyoxal probe. We apply the method to blood and plasma to demonstrate the impact of blood cell glyoxalase activity on plasma protein AGE formation. We move on to isolate proteins modified by the MG probe and accordingly can present the first general inventory of more than 100 proteins and 300 binding sites of the methylglyoxal probe on plasma as well as erythrocytic proteins. Some of the data could be validated against a number of in vivo and in vitro targets for advanced glycation previously known from the literature; the majority of proteins and specific sites however were previously unknown and may guide future research into MG and AGE to elucidate how these are functionally linked to diabetic disease and aging.


Subject(s)
Blood Proteins/analysis , Glycation End Products, Advanced/analysis , Proteome/analysis , Proteomics/methods , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/metabolism , Amino Acid Sequence , Blood Proteins/chemistry , Erythrocytes/metabolism , Glycation End Products, Advanced/chemistry , HeLa Cells , Humans , Lactic Acid , Protein Processing, Post-Translational , Proteome/chemistry , Pyruvaldehyde/chemistry
7.
Food Chem ; 164: 259-65, 2014 Dec 01.
Article in English | MEDLINE | ID: mdl-24996332

ABSTRACT

α-Dicarbonyl (α-DC) compounds were characterised in roasted (coffee, barley coffee) and in fermented (soy sauce) food matrices. Glyoxal (GO), methylglyoxal (MGO), diacetyl (DA) and 3-deoxyglucosone (3-DG) were found in all samples, and hydroxypyruvaldehyde and 5-hydroxypentane-2,3-dione in barley and soy. Cis and trans 3,4-dideoxyglucosone-3-ene (3,4-DGE) isomers and 4-glucosyl-5,6-dihydroxy-2-oxohexanal (4-G,3-DG) were found only in barley, and 3,4-DGE only in soy sauce with molasses. GO, MGO, and DA were quantified. Findings indicate that i) α-DC profiles depend on the food matrix and any technological treatments applied; ii) α-DC quantitation by HPLC requires matrix-specific, validated methods; iii) GO and MGO were the most abundant α-DCs; and iv) barley coffee was the matrix richest in α-DCs both qualitatively and quantitatively. In vitro simulated digestion reduced (coffee) or strongly increased (barley, soy sauce) free α-DC content. These findings suggest that α-DC bioavailability could actually depend not on food content but rather on reactions occurring during digestion.


Subject(s)
Coffea/metabolism , Coffee/metabolism , Deoxyglucose/analogs & derivatives , Digestion , Glyoxal/metabolism , Hordeum/metabolism , Pyruvaldehyde/metabolism , Soy Foods/analysis , Chromatography, High Pressure Liquid , Coffea/chemistry , Coffee/chemistry , Cooking , Deoxyglucose/chemistry , Deoxyglucose/metabolism , Diacetyl/chemistry , Diacetyl/metabolism , Glyoxal/chemistry , Hordeum/chemistry , Hot Temperature , Humans , Models, Biological , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/chemistry
8.
Magn Reson Chem ; 50(7): 502-10, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22615146

ABSTRACT

In the (13) C NMR spectra of methylglyoxal bisdimethylhydrazone, the (13) C-5 signal is shifted to higher frequencies, while the (13) C-6 signal is shifted to lower frequencies on going from the EE to ZE isomer following the trend found previously. Surprisingly, the (1) H-6 chemical shift and (1) J(C-6,H-6) coupling constant are noticeably larger in the ZE isomer than in the EE isomer, although the configuration around the -CH═N- bond does not change. This paradox can be rationalized by the C-H⋯N intramolecular hydrogen bond in the ZE isomer, which is found from the quantum-chemical calculations including Bader's quantum theory of atoms in molecules analysis. This hydrogen bond results in the increase of δ((1) H-6) and (1) J(C-6,H-6) parameters. The effect of the C-H⋯N hydrogen bond on the (1) H shielding and one-bond (13) C-(1) H coupling complicates the configurational assignment of the considered compound because of these spectral parameters. The (1) H, (13) C and (15) N chemical shifts of the 2- and 8-(CH(3) )(2) N groups attached to the -C(CH(3) )═N- and -CH═N- moieties, respectively, reveal pronounced difference. The ab initio calculations show that the 8-(CH(3) )(2) N group conjugate effectively with the π-framework, and the 2-(CH(3) )(2) N group twisted out from the plane of the backbone and loses conjugation. As a result, the degree of charge transfer from the N-2- and N-8- nitrogen lone pairs to the π-framework varies, which affects the (1) H, (13) C and (15) N shieldings.


Subject(s)
Hydrazones/chemistry , Protons , Pyruvaldehyde/analogs & derivatives , Carbon Isotopes , Magnetic Resonance Spectroscopy/standards , Molecular Structure , Nitrogen Isotopes , Pyruvaldehyde/chemistry , Reference Standards , Stereoisomerism
9.
J Food Sci ; 76(3): H90-6, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21535836

ABSTRACT

The carbonyl stress that leads to the formation of advanced glycation end products (AGEs) has drawn much attention recently because of its micro- and macrovascular implications. During monitoring of methylglyoxal (MG), the efficiency of phenolics to directly trap MG can be demonstrated. Twenty compounds consisting of a single benzene ring structure with the addition of at least one hydroxyl group were allowed to react with MG at 37 °C for 1 h under physiological conditions in pH 7.4 phosphate buffer solution. Compounds composed of a benzene structure with a mono-hydroxyl substitute cannot react with MG. Among benzenediols and di-hydroxyl benzoic acids, only hydroquinone reacted with MG and showed a 13% decrease in MG. Nevertheless, high reactivity was shown for 3 benzenetriols. The percentages of MG remaining were 45%, 51%, and 36% for pyrogallol, 1,2,4-trihydroxybenzene, and 1,3,5-trihydroxybenzene, respectively. When a carboxyl group is added to the benzenetriols, steric hindrance and carbon electron charges on benzene ring are the influential factors in reactivity. Using computational chemistry calculations, a carbon electron charge of -0.24 was the minimum value for high reactivity.


Subject(s)
Drug Discovery , Flavonoids/chemistry , Free Radical Scavengers/chemistry , Hydroxybenzoates/chemistry , Phenols/chemistry , Pyruvaldehyde/chemistry , Glycation End Products, Advanced/antagonists & inhibitors , Hydroquinones/chemistry , Polyphenols , Pyruvaldehyde/analogs & derivatives , Structure-Activity Relationship
10.
Eur J Med Chem ; 46(5): 1935-41, 2011 May.
Article in English | MEDLINE | ID: mdl-21397997

ABSTRACT

In the study of previously reported modulators of CFTR chloride channels that are cyclic methylglyoxal (MG) diadducts (CMGD) to aromatic α-aminoazaheterocycles, we optimized a new expeditious one pot route for preparing in water novel aromatic polycyclic azaheterocycles and described 5-pyrimidinols antioxidants through the formation of 2-oxoaldehyde diadducts to aromatic α-aminoazaheterocycles, amidines, guanidines and thiourea. In regard to the importance as biomarkers of diabetic complications of the 5-pyrimidinols "argpyrimidines" formed in proteins from MG and arginine residues, we demonstrated that argpyrimidines are slowly formed under physiological conditions from CMGD to arginine derivatives according to the synthesis route described. Among the 5-pyrimidinol derivatives prepared, two polycyclic derivatives appeared to inhibit strongly the activity of CFTR channels in wt-CHO cells.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/antagonists & inhibitors , Drug Discovery , Ornithine/analogs & derivatives , Pyrimidines/pharmacology , Pyruvaldehyde/chemistry , Animals , CHO Cells , Chemistry, Physical , Cricetinae , Cricetulus , Molecular Conformation , Ornithine/chemistry , Pyrimidines/chemical synthesis , Pyrimidines/chemistry , Pyruvaldehyde/analogs & derivatives , Stereoisomerism , Structure-Activity Relationship
11.
Chem Pharm Bull (Tokyo) ; 58(9): 1127-31, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20823588

ABSTRACT

In continuing our program aimed to search for potent drugs for bacterial infections, a series of 3-(4-halophenyl)-3-oxopropanal and their derivatives were designed, synthesized and their antibacterial activities in vitro against both Gram-positive bacteria Staphylococcus aureus and Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa were evaluated. Compounds 7, 8, 13-16, 21 and 22 had moderate antibacterial activities against Staphylococcus aureus (minimal inhibitory concentration (MIC) <16 microg/ml), suggesting that the introduction of mono-methoxyamine or ethoxyamine moiety might play an important role in determining the potent antibacterial activities. Furthermore, the antibacterial activities of select compounds 7, 15 and 16 against the clinically important pathogenic bacteria-methicillin-resistant Staphylococcus aureus (MRSA) were also investigated. Results showed that these compounds exhibited more potent activities than the well-known antibacterial agents Houttuynin and Levofloxacin.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Pyruvaldehyde/analogs & derivatives , Anti-Bacterial Agents/chemical synthesis , Escherichia coli/drug effects , Escherichia coli Infections/drug therapy , Humans , Methicillin-Resistant Staphylococcus aureus/drug effects , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , Pyruvaldehyde/chemical synthesis , Pyruvaldehyde/chemistry , Pyruvaldehyde/pharmacology , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Structure-Activity Relationship
12.
Ann N Y Acad Sci ; 1126: 231-4, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18079474

ABSTRACT

Increased formation of the reactive dicarbonyl compound methylglyoxal (MGO) and MGO-derived advanced glycation end products (AGEs) seems to be implicated in endothelial dysfunction and the development of diabetic vascular complications. MGO reacts with arginine residues in proteins to generate the major glycated adducts 5-hydro-5-methylimidazolone (MG-H1) and argpyrimidine (AP). We investigated whether the free forms of these adducts contribute to vascular cell dysfunction by inhibition of endothelial nitric oxide synthase (eNOS). MG-H1 and AP were synthesized and purified by reversed-phase chromatography, and the conversion of labeled L-arginine to L-citrulline was used to monitor eNOS activity. In contrast to the endogenous eNOS inhibitor asymmetric dimethylarginine (half maximal inhibitory concentration, approximately 5 micromol/L), pathophysiological concentrations of MGO and MG-H1 and AP did not inhibit eNOS activity. Although MGO-derived AGEs are implicated in the development of diabetic vascular complications, this study indicates that this is not mediated via direct inhibition of eNOS activity.


Subject(s)
Arginine/pharmacology , Endothelium, Vascular/enzymology , Nitric Oxide Synthase Type III/antagonists & inhibitors , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/pharmacology , Umbilical Veins/enzymology , Anthracenes/pharmacology , Arginine/analogs & derivatives , Enzyme Inhibitors/pharmacology , Humans , Propane/analogs & derivatives , Propane/pharmacology
13.
J Gerontol A Biol Sci Med Sci ; 62(4): 427-33, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17452738

ABSTRACT

BACKGROUND: Oxidative stress (OS) and inflammatory mediators increase with aging. The levels of advanced glycation endproducts (AGEs), prooxidant factors linked to chronic diseases such as diabetes, cardiovascular disease, and renal disease, also increase with aging. AGEs are readily derived from heat-treated foods. We propose that the excess consumption of certain AGEs via the diet enhances OS and inflammatory responses in healthy adults, especially in elderly persons. METHODS: We examined 172 young (<45 years old) and older (>60 years old) healthy individuals to determine whether the concentration of specific serum AGEs (N(epsilon)-carboxymethyl-lysine [CML] or methylglyoxal [MG] derivatives) were higher in older compared to younger persons and whether, independent of age, they correlated with the intake of dietary AGEs, as well as with circulating markers of OS and inflammation. RESULTS: Body weight, body mass index (BMI), and serum AGE, CML, and MG derivatives were higher in older participants, independent of gender. Serum CML correlated with levels of 8-isoprostanes (r = 0.448, p =.0001) as well as with Homeostasis Model Assessment index (HOMA), an index of insulin resistance (r = 0.247, p =.044). The consumption of dietary AGEs, but not of calories, correlated independently with circulating AGEs (CML: r = 0.415, p =.0001 and MG: r = 0.282, p =.002) as well as with high sensitivity C-reactive protein (hsCRP) (r = 0.200, p =.042). CONCLUSIONS: Circulating indicators of AGEs (CML and MG derivatives), although elevated in older participants, correlate with indicators of inflammation and OS across all ages. Indicators of both AGEs and OS are directly influenced by the intake of dietary AGEs, independent of age or energy intake. Thus, reduced consumption of these oxidants may prove a safe economic policy to prevent age-related diseases, especially in an aging population.


Subject(s)
Aging/blood , Diet , Glycation End Products, Advanced/administration & dosage , Glycation End Products, Advanced/blood , Inflammation/etiology , Oxidative Stress , Adult , Aged , Aged, 80 and over , C-Reactive Protein/metabolism , Dinoprost/analogs & derivatives , Dinoprost/blood , Energy Intake , Female , Humans , Insulin Resistance , Lysine/analogs & derivatives , Male , Middle Aged , Pyruvaldehyde/analogs & derivatives
14.
Chem Res Toxicol ; 19(1): 130-8, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16411666

ABSTRACT

We searched for mutagens that react with 2'-deoxyguanosine (dGuo) in model systems of lipid peroxidation. To autoxidation systems of methyl linoleate (model of omega-6 fat), methyl alpha-linolenate (MLN) (model of omega-3 fat), and commercial salad oil, dGuo was added. The reaction mixtures were analyzed by HPLC. Six adducts were detected, and their structures were determined by 1H and 13C NMR, UV, and mass spectra and by comparison with synthetic authentic samples. The mutagens that reacted with dGuo to form these adducts were proposed as glyoxal, glyoxylic acid, ethylglyoxal, and 4-oxo-2-hexenal (4-OHE). The formation of 8-hydroxy-dGuo, an oxidized product of dGuo, was also detected in the model reaction mixtures. Among them, glyoxal and glyoxylic acid are known mutagens, while ethylglyoxal and 4-OHE, produced from MLN, have not been reported as mutagens thus far. We confirmed the mutagenic activity of 4-OHE with Salmonella strains, TA100 and TA104, without S9 mix. These compounds may be involved in lipid peroxide-related cancers.


Subject(s)
Aldehydes/chemistry , Deoxyguanosine/chemistry , Lipid Peroxidation , Mutagens/chemistry , Aldehydes/analysis , Aldehydes/toxicity , Deoxyguanosine/analysis , Glyoxylates/analysis , Glyoxylates/chemistry , Hemin , Linoleic Acids , Linolenic Acids , Models, Biological , Mutagenicity Tests , Mutagens/analysis , Mutagens/toxicity , Plant Oils , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/analysis , Pyruvaldehyde/chemistry , Salmonella/drug effects , Salmonella/genetics
15.
Ukr Biokhim Zh (1978) ; 62(2): 13-22, 1990.
Article in Russian | MEDLINE | ID: mdl-2195730

ABSTRACT

The present notions on the metabolism of methylglyoxal, an endogenic controller of cellular proliferation, are adduced. The interaction between metabolism of methylglyoxal and that of carbohydrates, proteins and lipids is demonstrated. The metabolic chart has been worked out and enzymes catalyzing methylglyoxal metabolic reactions are determined. The effect of methylglyoxal and its bisguanylhydrazones derivatives on the processes of cellular proliferation control has been examined.


Subject(s)
Aldehydes/metabolism , Antineoplastic Agents , Pyruvaldehyde/metabolism , Animals , Cell Division/drug effects , Humans , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/pharmacology
18.
Biochem Pharmacol ; 34(8): 1157-64, 1985 Apr 15.
Article in English | MEDLINE | ID: mdl-3994738

ABSTRACT

Hydroxypyruvaldehyde is a substrate for the red cell glyoxalase system. It was metabolized by glyoxalase I with reduced glutathione to S-glyceroyl glutathione which was subsequently enzymatically hydrolyzed to reduced glutathione and glycerate by glyoxalase II. There was a competing spontaneous reaction of hydroxypyruvaldehyde with oxygen, which produced hydrogen peroxide, inducing oxidative metabolism in hydroxypyruvaldehyde-treated red cells. The incubation of red cells with hydroxypyruvaldehyde produced a stimulation in the flux of glucose oxidized through the hexose monophosphate shunt pathway, a stimulation in lactate production with a decrease in pyruvate production in the Embden-Meyerhoff pathway, an oxidation of reduced pyridine nucleotides and reduced glutathione to their oxidized cogeners, and changes in the oxidative status of hemoglobin. Overall, the majority of hydroxypyruvaldehyde consumption in red cell suspensions appeared to occur via non-oxidative routes, e.g. glyoxalase and/or 2-ketoaldehyde dehydrogenase, and non-enzymic protein binding. Although the observed oxidative metabolism induced by hydroxypyruvaldehyde in red cells was not severe (reduced glutathione levels in hydroxypyruvaldehyde-treated red cells were ca. 80% of the control values in untreated cells), the oxidative effects may be important in red cell ageing processes.


Subject(s)
Erythrocytes/drug effects , Malonates , Malondialdehyde/analogs & derivatives , Adult , Blood Glucose/metabolism , Erythrocytes/metabolism , Free Radicals , Glutathione/blood , Hemoglobins/metabolism , Humans , In Vitro Techniques , Lactates/blood , Lactic Acid , Malondialdehyde/blood , Malondialdehyde/pharmacology , NAD/blood , NADP/blood , Oxidation-Reduction , Oxygen Consumption/drug effects , Pentose Phosphate Pathway/drug effects , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/pharmacology , Pyruvates/blood , Pyruvic Acid
20.
Biochem J ; 217(3): 615-22, 1984 Feb 01.
Article in English | MEDLINE | ID: mdl-6324741

ABSTRACT

Glyceraldehyde and other simple monosaccharides oxidize oxyhaemoglobin to methaemoglobin in phosphate buffer at pH 7.4 and 37 degrees C, with the concomitant production of H2O2 and an alpha-oxo aldehyde derivative of the monosaccharide. Simple monosaccharides also reduce methaemoglobin to ferrohaemichromes (non-intact haemoglobin) at pH 7.4 and 37 degrees C. Carbonmonoxyhaemoglobin is unreactive towards oxidation by autoxidizing glyceraldehyde. Free-radical production from autoxidizing monosaccharides with haemoglobins was observed by the e.s.r. technique of spin trapping with the spin trap 5,5-dimethyl-l-pyrroline N-oxide. Hydroxyl and l-hydroxyalkyl radical production observed from monosaccharide autoxidation was quenched in the presence of oxyhaemoglobin and methaemoglobin. The haemoglobins appear to quench the free radicals by reaction with the free radicals and/or the ene-diol precursor of the free radical.


Subject(s)
Glyceraldehyde/metabolism , Monosaccharides/metabolism , Oxyhemoglobins/metabolism , Chemical Phenomena , Chemistry , Electron Spin Resonance Spectroscopy , Ferrous Compounds/metabolism , Free Radicals , Hemoglobins/metabolism , Humans , Kinetics , Methemoglobin/metabolism , Oxidation-Reduction , Oxygen Consumption , Pyruvaldehyde/analogs & derivatives , Pyruvaldehyde/metabolism , Spectrophotometry
SELECTION OF CITATIONS
SEARCH DETAIL
...